Last reviewed · How we verify
NCT05131802
Bile Reflux Gastropathy: Prevalence and Risk Factors After Therapeutic Biliary Interventions
trial testing upper GIT endescopy in Dyspepsia in 288 participants. Completed in 15 December 2020.
15 December 2020
Quick facts
| Lead sponsor | Zagazig University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 288 |
| Start date | 1 January 2018 |
| Primary completion | 15 December 2020 |
| Estimated completion | 15 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- upper GIT endescopy
Conditions studied
- Dyspepsia — all drugs for Dyspepsia →
- Heartburn — all drugs for Heartburn →
- Bile Reflux — all drugs for Bile Reflux →
Sponsor
Zagazig University
Who can join
Eligibility, any sex, with Dyspepsia or Heartburn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bile reflux gastropathy is caused by the backward flow of duodenal fluid into the stomach. A retrospective cohort study was performed to declare if the therapeutic biliary interventions cause bile reflux gastropathy, and to estimate its prevalence and risk factors, and to evaluate the gastric mucosa endoscopic and histopathologic changes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Bile reflux gastropathy: Prevalence and risk factors after therapeutic biliary interventions: A retrospective cohort study.
Othman AAA, Dwedar AAZ, ElSadek HM, AbdElAziz HR, et al · · 2021 · cited 7× · PMID 34934491 · DOI 10.1016/j.amsu.2021.103168
Verify or expand the search:
- PubMed search for NCT05131802
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dyspepsia
Currently open trials in the same condition.
- NCT06941545 — High Resolution Gastric Mapping and Gastroduodenal Manometry · NA · recruiting
- NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting
- NCT06755671 — A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms · recruiting
- NCT06422052 — Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspep · recruiting
- NCT05810168 — Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia · NA · recruiting
Other Zagazig University trials
Trials by the same sponsor.
- NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
- NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
- NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
- NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
- NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05131802 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zagazig University
- Last refreshed: 8 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05131802.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing